Treatment-resistant inflammatory myopathy

Best Practice and Research: Clinical Rheumatology

Volumn 24, Issue 3, 2010, Pages 427-440

  Mann, Herman F ^a   Vencovsky, Jiri ^a   Lundberg, Ingrid E ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

dermatomyositis; inclusion body myositis (IBM); polymyositis; treatment resistant myositis

Indexed keywords

ALEMTUZUMAB; ALPHA INTERFERON; AMPHOTERICIN; AZATHIOPRINE; CIMETIDINE; CYCLOSPORIN; CYCLOSPORIN A; DIURETIC AGENT; GLUCOCORTICOID; HYDROXYUREA; HYPOCHOLESTEROLEMIC AGENT; IMATINIB; IMMUNOGLOBULIN; LABETALOL; LAMOTRIGINE; LAXATIVE; LEVODOPA; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLAMINE; PHENYTOIN; PROPOFOL; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; TACROLIMUS; TRYPTOPHAN; UNINDEXED DRUG; ZIDOVUDINE; IMMUNOSUPPRESSIVE AGENT;

ANAMNESIS; ANTIBODY DETECTION; ANTISYNTHETASE SYNDROME; ATTENTION; CLINICAL FEATURE; CLINICAL TRIAL; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOCRINE DISEASE; ENZYME SUBUNIT; HUMAN; HYPOKALEMIC MYOPATHY; IMMUNOSUPPRESSIVE TREATMENT; METABOLIC DISORDER; MITOCHONDRIAL MYOPATHY; MOLECULAR WEIGHT; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOPATHY; MYOSITIS; NECROTIZING MYOPATHY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; SCLERODERMA; TOXIC MYOPATHY; TREATMENT RESPONSE; IMMUNOLOGY; TREATMENT FAILURE;

DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; POLYMYOSITIS; TREATMENT FAILURE;

EID: 77956631797     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2009.12.008     Document Type: Review

References (54)

1. L. Christopher-Stine, and P.H. Plotz Adult inflammatory myopathies Best Pract Res Clin Rheumatol 18 2004 331 344
2. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis N Engl J Med 292 1975 344 347
3. M. Needham, and F.L. Mastaglia Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches Lancet Neurol 6 2007 620 631
4. H. Alexanderson, and I.E. Lundberg The role of exercise in the rehabilitation of idiopathic inflammatory myopathies Curr Opin Rheumatol 17 2005 164 171
5. F.W. Miller, L.G. Rider, and Y.L. Chung Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies Rheumatology (Oxford) 40 2001 1262 1273
6. E.M. Dugan, A.M. Huber, and F.W. Miller Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies Dermatol Online J 15 2009 1
7. P. Gerami, J.M. Schope, and L. McDonald A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies J Am Acad Dermatol 54 2006 597 613
8. E.P. Hoffman, D. Rao, and L.M. Pachman Clarifying the boundaries between the inflammatory and dystrophic myopathies: insights from molecular diagnostics and microarrays Rheum Dis Clin North Am 28 2002 743 757
9. N. Chahin, and A.G. Engel Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM Neurology 70 2008 418 424
10. R.J. Walsh, and A.A. Amato Toxic myopathies Neurol Clin 23 2005 397 428
11. A. Seidler, and A. Gottlieb Dermatomyositis induced by drug therapy J Am Acad Dermatol 59 2008 872 880
12. Y. Yazici, and L.J. Kagen Clinical presentation of the idiopathic inflammatory myopathies Rheum Dis Clin North Am 28 2002 823 832
13. R.L. Wortmann, and S. DiMauro Differentiating idiopathic inflammatory myopathies from metabolic myopathies Rheum Dis Clin North Am 28 2002 759 778
14. I.E. Lundberg The heart in dermatomyositis and polymyositis Rheumatology (Oxford) 45 2006 18 21
15. L.G. Rider Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies Rheum Dis Clin North Am 28 2002 935 977
16. C. Marguerie, C.C. Bunn, and H.L. Beynon Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes Q J Med 77 1990 1019 1038
17. R. Brouwer, G.J. Hengstman, and W. Vree Egberts Autoantibody profiles in the sera of European patients with myositis Ann Rheum Dis 60 2001 116 123
18. Z. Betteridge, H. Gunawardena, and J. North Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia Rheumatology (Oxford) 46 2007 1005 1008
19. L. Hashish, E.P. Trieu, and P. Sadanandan Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome (abstract) Arthritis Rheum 52 2005 S312
20. I. Tillie-Leblond, M. Wislez, and D. Valeyre Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset Thorax 63 2008 53 59
21. K.B. Stone, C.V. Oddis, and N. Fertig Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy Arthritis Rheum 56 2007 3125 3131
22. A.H. Kao, D. Lacomis, and M. Lucas Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy Arthritis Rheum 50 2004 209 215
23. T. Miller, M.T. Al-Lozi, and G. Lopate Myopathy with antibodies to the signal recognition particle: clinical and pathological features J Neurol Neurosurg Psychiatry 73 2002 420 428
24. G.J. Hengstman, W.T. Vree Egberts, and H.P. Seelig Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen Ann Rheum Dis 65 2006 242 245
25. C. Marguerie, C.C. Bunn, and J. Copier The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl Medicine (Baltimore) 71 1992 327 336
26. I. Cavazzana, A. Ceribelli, and M. Quinzanini Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases Lupus 17 2008 727 732
27. I.N. Targoff, G. Mamyrova, and E.P. Trieu A novel autoantibody to a 155-kd protein is associated with dermatomyositis Arthritis Rheum 54 2006 3682 3689
28. K. Kaji, M. Fujimoto, and M. Hasegawa Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy Rheumatology (Oxford) 46 2007 25 28
29. H. Gunawardena, L.R. Wedderburn, and J. North Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis Rheumatology (Oxford) 47 2008 324 328
30. H. Chinoy, N. Fertig, and C.V. Oddis The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis Ann Rheum Dis 66 2007 1345 1349
31. H. Gunawardena, L.R. Wedderburn, and H. Chinoy Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis Arthritis Rheum 60 2009 1807 1814
32. S. Sato, M. Hirakata, and M. Kuwana Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis Arthritis Rheum 52 2005 1571 1576
33. S. Sato, K. Hoshino, and T. Satoh RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease Arthritis Rheum 60 2009 2193 2200
34. Z.E. Betteridge, H. Gunawardena, and H. Chinoy Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis Ann Rheum Dis 68 2009 1621 1625
35. L. Christopher-Stine, G. Hong, and L. Casciola-Rosen A novel autoantibody against 200/100 Kd proteins is associated with necrotizing myopathy (abstract) Arthritis Rheum 60 2009 S430
36. S. Lovitt, S.L. Moore, and F.A. Marden The use of MRI in the evaluation of myopathy Clin Neurophysiol 117 2006 486 495
37. J. Tomasova-Studynkova, F. Charvat, K. Jarosova, and J. Vencovsky The role of MRI in the assessment of polymyositis and dermatomyositis Rheumatology 46 2007 1174 1179
38. R.V. Curiel, R. Jones, and K. Brindle Magnetic resonance imaging of the idiopathic inflammatory myopathies: structural and clinical aspects Ann N Y Acad Sci 1154 2009 101 114
39. M.C. Dalakas Muscle biopsy findings in inflammatory myopathies Rheum Dis Clin North Am 28 2002 779 798
40. J. van der Pas, G.J. Hengstman, and H.J. ter Laak Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies J Neurol Neurosurg Psychiatry 75 2004 136 139
41. A. Jain, M.C. Sharma, and C. Sarkar Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies Arch Pathol Lab Med 131 2007 1070 1076
42. I. Lundberg, A.K. Kratz, H. Alexanderson, and M. Patarroyo Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis Arthritis Rheum 43 2000 336 348
43. V. Madan, H. Chinoy, C.E. Griffiths, and R.G. Cooper Defining cancer risk in dermatomyositis Clin Exp Dermatol 34 2009 451 455
44. L. Villalba, J.E. Hicks, and E.M. Adams Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens Arthritis Rheum 41 1998 392 399
45. M.C. Dalakas, I. Illa, and J.M. Dambrosia A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis N Engl J Med 329 1993 1993 2000
46. S. Barbasso Helmers, M. Dastmalchi, and H. Alexanderson Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies Ann Rheum Dis 66 2007 1276 1283
47. C.N. Pisoni, M.J. Cuadrado, and M.A. Khamashta Mycophenolate mofetil treatment in resistant myositis Rheumatology (Oxford) 46 2007 516 518
48. Y. Yamasaki, H. Yamada, and M. Yamasaki Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis Rheumatology (Oxford) 46 2007 124 130
49. M.R. Wilkes, S.M. Sereika, and N. Fertig Treatment of antisynthetase-associated interstitial lung disease with tacrolimus Arthritis Rheum 52 2005 2439 2446
50. E.H. Noss, D.L. Hausner-Sypek, and M.E. Weinblatt Rituximab as therapy for refractory polymyositis and dermatomyositis J Rheumatol 33 2006 1021 1026
51. J.B. Arlet, D. Dimitri, and C. Pagnoux Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP) Neuromuscul Disord 16 2006 334 336
52. A. Furlan, C. Botsios, and A. Ruffatti Antisynthetase syndrome with refractory polyarthritis and fever successfully treated with the IL-1 receptor antagonist, anakinra: a case report Joint Bone Spine 75 2008 366 367
53. H. Alexanderson, C.H. Stenström, G. Jenner, and I. Lundberg The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis Scand J Rheumatol 29 2000 295 301
54. Dalakas, G. Rakocevic, and J. Schmidt Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis Brain 132 2009 1536 1544